Consolidated statement of cash flows (IFRS)

Consolidated profit

Income taxes

Interest income/expenses

Result of investments carried at equity

Result from the change in fair value of contingent purchase price obligations

Depreciation and amortization

Result from the disposal of intangible assets and property, plant and equipment

Other non-cash income/expenses

Interest and dividends received

Interest paid

Income taxes paid

Change in inventories

Change in trade receivables

Change in other assets

Change in trade payables

Change in provisions and financial liabilities

Change in other liabilities

Cash flow from operating activities

Cash outflow for investments in property, plant and equipment

Cash outflow for investments in other intangible assets

Proceeds from the disposal of intangible assets and property, plant and equipment

Cash outflow for investments in financial assets

Change in treasury receivables

Acquisition of consolidated subsidiaries less cash received

Cash flow from investing activities

Change in current bank liabilities

Proceeds from loans

Change in treasury payables

Repayment of leasing liabilities

Purchase of own shares

Dividends paid to shareholders of Carl Zeiss Meditec AG

Dividends paid to non-controlling interests

Cash flow from financing activities

Effect of exchange rate fluctuation on cash and cash equivalents

Change in cash and cash equivalents

Cash and cash equivalents as of 1 October

Cash and cash equivalents as of 30 September